Aesun Shin; Sooyoung Cho; Sven Sandin; Marie Lof; Moon Young Oh; Elisabete Weiderpass

doi:10.4143/crt.2019.550

Articles

Page Path: HOME > Cancer Res Treat > Volume 52(3); 2020 > Article

Original Article Omega-3 and -6 Fatty Acid Intake and Colorectal Cancer Risk in Swedish Women’s Lifestyle and Health Cohort: Aesun Shin, MD, PhD^1,2,, Sooyoung Cho, MS^1,2, Sven Sandin, PhD^3,4,5, Marie Lof, PhD^6,7, Moon Young Oh, MD⁸, Elisabete Weiderpass, MD, PhD^9,; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2020;52(3):848-854.
DOI: https://doi.org/10.4143/crt.2019.550
Published online: March 6, 2020

¹Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

²Cancer Research Institute, Seoul National University, Seoul, Korea

³Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

⁴Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA

⁵Seaver Autism Center for Research and Treatment at Mount Sinai, New York, NY, USA

⁶Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden

⁷Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

⁸Department of Surgery, Seoul National University Hospital, Seoul, Korea

⁹International Agency for Research on Cancer, Lyon, France

Correspondence: Aesun Shin, MD, PhD Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea
Tel: 82-2-740-8331 Fax: 82-2-747-4830 E-mail: shinaesun@snu.ac.kr

Co-correspondence: Elisabete Weiderpass, MD, PhD International Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France
Tel: 33-472-738-684 Fax: 33-472-738-564 E-mail: director@iarc.fr

• Received: September 25, 2019 • Accepted: March 5, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

9,182 Views
187 Download
16 Web of Science
17 Crossref
16 Scopus

prev next

Full Article

Download PDF

Abstract

Purpose
We aimed to assess the association between the dietary intake of fish-derived omega-3 polyunsaturated fatty acids and the risk of colorectal cancer among Swedish women.
Materials and Methods
A total of 48,233 women with information on dietary intake were included in the analysis. Participants were followed for incident colorectal cancer until 31 December 2012. Cox proportional hazard models were used to assess the association between baseline fatty acid intake and colorectal cancer risk. All analyses were stratified by colon and rectal cancers.
Results
During a median of 21.3 years of follow-up, a total of 344 colorectal cancer cases were ascertained. Although there was no overall association between omega-3 fatty acid intake and colorectal cancer risk, high intake of fish-derived docosahexaenoic acid was associated with reduced risk of rectal cancer (hazard ratios for the third and the highest quartiles were 0.59 (95% confidence interval [CI], 0.37 to 0.96) and 0.62 (95% CI, 0.39 to 0.98), respectively).
Conclusion
In conclusion, we found only limited support for an association between omega-3 polyunsaturated fatty acids and colorectal cancer in a large Swedish cohort of middle-aged women.
Key words: Colorectal neoplasms, Diet, Prevention

Introduction

Despite the anticarcinogenic effects of omega (n)-3 fatty acids, especially long-chain polyunsaturated fatty acids (PUFAs), demonstrated in animal studies [1], epidemiological studies have not shown consistent results to support their protective effect on cancers. Meta-analyses of prospective studies show no overall association between n-3 fatty acid intake and colorectal cancer [2,3] and marginally significant inverse association between fish intake, which is the most important dietary source of n-3 fatty acids, and colorectal cancer risk [3,4]. However, it is noteworthy that the protective effect of marine n-3 PUFAs is more prominent when the study population is followed for longer periods [4]. Although not significant, a nonlinear inverse dose-response association was observed at up to 1 g/day of murine n-3 PUFA intake [2,3]. In addition, the association differs by sex and anatomical subsites of colorectal cancer [5].

One previous study from the Swedish Mammography Cohort, which used similar methods to measure dietary fatty acids, showed no association between fatty acid intake and colorectal cancer risk during up to 11 years of follow-up [6]. Here, we utilized the Swedish Women’s Lifestyle and Health (WLH) cohort, which consisted of women aged 29-49 and followed for more than 20 years, to clarify the potential beneficial effect of n-3 PUFAs on colorectal cancer risk. The primary study objective was to examine the association between the dietary intake of fish-derived n-3 PUFAs (eicosapentaenoic acid and docosahexaenoic acid [DHA]) and the risk of colorectal cancer in the WLH cohort. Additionally, we also included total n-3 and n-6 fatty acid intake. Possible differences in the association by colorectal cancer subsites were addressed.

Materials and Methods

1. Study population

The study population included participants in the Swedish WLH cohort (https://ki.se/en/meb/womens-lifestyle-andhealth) that answered the baseline (1991-1992) questionnaire [7].

Among 49,258 participants, those who were diagnosed with colorectal cancer before enrollment (n=15), who emigrated without reimmigration (n=34), and who were outside the 1st and 99th percentiles of energy intake (n=986) were excluded. Finally, 48,233 participants were included in the analysis.

Dietary habits were collected through a validated food-frequency questionnaire (FFQ) that covered 80 food items and beverages. The detailed method used to estimate the dietary intake of n-3/n-6 fatty acids and total calories was described in a previous study [8]. Information on demographic and lifestyle factors, weight, and height was also collected from a self-administered questionnaire [7].

Colorectal cancer incidence was ascertained from the Swedish Cancer Register by using the International Classification of Diseases, 9th revision (ICD-9) codes 153 and 154.

The dietary intake of n-3/n-6 fatty acids was categorized into quartiles (lowest 25%, 25-50%, 50-75%, and highest 25%). Potential confounders were selected based on a previous study [9]. Potential confounders were categorized as follows, as in previous publications describing this cohort [9,10]: body mass index (kg/m²; < 25, 25-30, ≥ 30, or missing), education (years; ≤ 10, 11-13, or > 13), smoking history (never or ever), and alcohol intake (g/day; < 5, 5-25, ≥ 25). Due to the relatively high percentage of missing data, the intake frequency of meat (n=13,088) and sausage (n=19,030) were not considered in the multivariate analysis. Although physical activity is an important protective factor for colorectal cancer, the questionnaire item for physical activity only addressed subjective activity level rather than frequency or intensity; therefore, we did not include this variable as a confounder.

2. Statistical analysis

Cox proportional hazard regression models were fitted to the data with attained age as the time scale [11]. Participants were censored when any of the following events occurred after entry into the cohort: colorectal cancer, death, emigration or 31 December 2012. The hazard ratios (HRs) of cancer were estimated by calculating the HRs from the Cox regression models. We calculated the HR of colorectal cancer for each of the three quantiles of exposure to n-3/n-6 fatty acids by using the lowest quartile as a reference and intake level as a continuous variable. Energy adjustment was performed by the residual method. The p-trend was estimated by using the order of the quartile groups. The proportional hazards assumption was checked by graphs of scaled Schoenfeldt residuals versus time. The analyses for colon cancer and rectal cancer were conducted separately.

All tests of statistical hypotheses were done on the 2-sided 5% level of significance corresponding to the use of two-sided 95% confidence intervals (CIs). No adjustment for multiple statistical tests was performed.

3. Ethical statement

All participants provided an informed consent to participate in the study and the study was approved by the Regional Ethics Committee in Uppsala and the Regional Ethics Committee at Karolinska Institutet, Stockholm (Dnr: 210-93, 1993; Dnr: 02-541, 2002).

Results

During a median of 21.3 years of follow-up, a total of 334 colorectal cancer cases were ascertained. Among them, 201 were colon cancer and 133 were rectal cancer. When the participants were categorized by total n-3 intake levels, the four groups showed differences in the distribution of age at enrollment, body mass index, smoking habits, alcohol intake amount, and total energy intake (Table 1). The quartile categories of n-3 and n-6 fatty acid intake are provided in Table 2. Fish-derived n-3 contributed to approximately 17% of the total n-3 fatty acid intake.

Table 3 shows the association between n-3/n-6 intake and colorectal cancer risk. There were no statistically significant associations between n-3 fatty acid intake and colorectal cancer risk. However, a high intake of n-6 fatty acids, especially linoleic acid, showed an increased risk for colorectal cancer (HR for the highest quartile, 1.40 [95% CI, 1.02 to 1.92]; p-trend=0.038). Stratified by anatomical subsites, the statistically significant association persisted only for rectal cancer. In addition, a high intake of fish-derived DHA intake was associated with a reduced risk of rectal cancer (HR for the third and highest quartiles compared to the lowest quantile, 0.59 [95% CI, 0.37 to 0.96] and 0.62 [95% CI, 0.39 to 0.98], respectively). All the models fit the proportional hazard assumption.

Discussion

In a large population-based cohort, we found little support for an association between fish-derived n-3 PUFAs and colorectal cancer.

Fish are the main dietary source of long-chain n-3 fatty acids, which have been suggested to play a protective role in colorectal cancer development. Although some studies have demonstrated an inverse relationship between fish consumption and colorectal cancer [4,12,13], others have not found a clear association [14-16]. In line with previous meta-analyses and pooled analyses that did not find an inverse association between fish intake and colorectal cancer risk [17,18], a comprehensive review by the World Cancer Research Fund concluded that the association between fish and colorectal cancer is “limited-suggestive” [3]. In a recent study from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts, the total intakes of fish, fatty fish and lean fish were associated with a reduced risk for colorectal cancer [19].

Previous studies applying subgroup analysis for subsites of colorectal cancer did not find a clear difference in the risk by subsites, although the pooled HR of fish intake for rectal cancer was slightly lower than the pooled HR for colon cancer (HR per 100 g/day increment: 0.84 [95% CI, 0.69 to 1.02] for rectal cancer and 0.91 [95% CI, 0.80 to 1.03] for colon cancer) [3]. It has been suggested that subsites of colorectal cancer show different risk factor profiles due to differences in embryological origins, physiological function, fecal composition, bile acid metabolism, intestinal transit time, and metabolizing enzyme activity [20]. In our study, fish-derived omega-3 intake was associated with a reduced risk for rectal cancer in the highest intake group. Different susceptibilities to fish oil intake could be explained by more fermentation reactions in the proximal colon and higher concentrations of N-nitroso compounds exposure markers, e.g., 6-O-methyldeoxyguanosine in the distal colon [2]. In addition, a recent microbiome study suggested that supplementation with krill oil resulted in differential effects on the microbial community at different gut locations in mice [21].

A variety of experimental studies and different clinical trials have substantiated the beneficial role of omega-3 PUFAs in preventing the pathogenesis of colorectal cancers [1]. Antineoplastic activity has been related to the regulatory effects exhibited by omega-3 PUFAs on cell proliferation and apoptosis [22]. Antiangiogenic and antimetastatic effects have also been reported for these fatty acids [22]. Other suggested mechanisms include the suppression of arachidonic acid-derived eicosanoid biosynthesis, which is related to altered immune response to cancer cells and inflammation, alteration of estrogen metabolism, and altering the production of free radicals and reactive oxygen species [1]. Finally, it has been suggested that omega-3 PUFAs may act as adjuvant therapeutic agents that sensitize tumors, including colon cancer, to different antineoplastic drugs [23,24].

High intake of linoleic acid showed an increased risk for colorectal cancer in the current study. Although animal models suggest that n-6 fatty acids promote colorectal cancer [1], epidemiological evidence has not shown a conclusive association [1,5]. Therefore, the potential elevated risk of colorectal cancer among individuals with a high intake of n-6 fatty acids needs to be further elucidated in other prospective studies.

The major strengths of our study include the completeness of the follow-up in a large population-based sample and the relatively longer follow-up periods than other prospective studies, which allows us to assess the long-term effect of diet on cancer risk. However, the limitations of the current study include a lack of detailed information on fish cooking methods, fish oil supplementation use, and oils used for cooking and a lack of repeated measures of exposure, which could have resulted in residual confounding. Although information on the frequency of fish oil supplements and fried fish consumption was available, these variables could not be included as potential confounding variables due to the high proportion of missing data. Additionally, important protective factors, such as anti-inflammatory drug use and physical activity, could not be considered.

We cannot rule out that our results were due to chance alone. We observed two statistically significant results in our primary analyses consisting of 27 statistical tests; 1.35 could be expected by chance alone. The intake levels of fatty acids were approximately 50% of the Swedish national data from the National Food Administration [25]. These differences could result from the different dietary assessment methods, e.g., an FFQ was used for our study, whereas a dietary record was used for the national data. However, the underestimation of the intake levels is more likely to be nondifferential and therefore less likely to affect the results of the current study. In addition, the intake levels of our study are comparable with those of other Swedish studies [26] and the EPIC study [19], which used an FFQ for dietary assessment.

In conclusion, we did not find strong evidence that a high intake of fish-derived long-chain PUFAs may reduce the risk of colorectal cancer among Swedish women, although a marginally significant reduced risk for rectal cancer was observed.

NOTES

Conflict of interest relevant to this article was not reported. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article, and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.

Acknowledgements

This study was supported by Korea Research Foundation (2017-R1A2B4009233).

Table 1.

Characteristics of study population by omega-3 intake quartile at baseline

Characteristic		Entire cohort participants	Energy-adjusted omega-3 intake quartile (g/day)				p-value
Characteristic		Entire cohort participants	Quartile 1 (lowest 25%) 0.12 to < 1.08	Quartile 2 (25th to 50th percentile) 1.08 to < 1.29	Quartile 3 (50th to 75th percentile) 1.29 to < 1.57	Quartile 4 (highest 25%) 1.57-22.66	p-value
No. of participants		48,223	12,056	12,055	12,056	12,056
Age at enrollment (yr)		39.7±5.7	38.2±5.7	39.0±5.7	40.1±5.7	41.4±5.5	< 0.001
Body mass index (kg/m²)
	< 25	33,639 (69.8)	8,391 (69.6)	8,611 (71.4)	8,521 (70.7)	8,116 (67.3)	< 0.001
	25-29	10,098 (20.9)	2,484 (20.6)	2,393 (19.9)	2,525 (20.9)	2,696 (22.4)
	≥ 30	2,675 (5.5)	677 (5.6)	649 (5.4)	610 (5.1)	739 (6.1)
	Missing	1,811 (3.8)	504 (4.2)	402 (3.3)	400 (3.3)	505 (4.2)
Education (yr)
	≤ 10	14,129 (29.3)	3,111 (25.8)	3,200 (26.5)	3,575 (29.7)	4,243 (35.2)	< 0.001
	11-13	18,513 (38.4)	4,843 (40.2)	4,805 (39.9)	4,552 (37.8)	4,313 (35.8)
	> 13	14,639 (30.4)	3,901 (32.4)	3,831 (31.8)	3,693 (30.6)	3,214 (26.7)
	Missing	942 (2.0)	201 (1.7)	219 (1.8)	236 (2.0)	286 (2.4)
Smoking
	Never	19,525 (40.5)	5,001 (41.5)	5,018 (41.6)	5,061 (42.0)	4,445 (36.9)	< 0.001
	Ever	28,550 (59.2)	7,019 (58.2)	7,013 (58.2)	6,963 (57.8)	7,555 (62.7)
	Missing	148 (0.3)	36 (0.3)	24 (0.2)	32 (0.3)	56 (0.5)
Alcohol intake (g/day)
	< 5	36,192 (75.1)	9,116 (75.6)	8,969 (74.4)	9,060 (75.1)	9,047 (75.0)	< 0.001
	5-25	11,822 (24.5)	2,852 (23.7)	3,029 (25.1)	2,956 (24.5)	2,985 (24.8)
	≥ 25	209 (0.4)	88 (0.7)	57 (0.5)	40 (0.3)	24 (0.2)
Energy intake (kcal/day)		1,555±452	1,738±462	1,666±416	1,538±390	1,280±396	< 0.001
Colorectal cancer cases		334	60	90	84	100
Follow-up (yr)		21.1±0.7	21.1±0.6	21.1±0.7	21.1±0.6	21.1±0.8
Cumulative follow-up (yr)		1,018,700.7	254,665.6	254,589.0	254,826.5	254,619.6

Values are presented as mean±standard deviation or number (%). p-values were calculated by chi-square test for categorical variables and ANOVA for continuous variables.

Table 2.

Quartile distribution of omega-3 and -6 fatty acid of study population (g/day)

Type		Quartile 1 (lowest 25%)	Quartile 2 (25th to 50th percentile)	Quartile 3 (50th to 75th percentile)	Quartile 4 (highest 25%)
Omega-3 fatty acid		0.12 to < 1.08	1.08 to < 1.29	1.29 to < 1.57	1.57 to 22.66
	Alpha-linolenic acid	0.12 to < 0.84	0.84 to < 0.98	0.98 to < 1.16	1.16 to 4.47
	Docosapentaenoic acid	0 to < 0.02	0.02 to < 0.03	0.03 to < 0.05	0.05 to 1.34
	Fish oil-derived omega-3	0 to < 0.12	0.12 to < 0.22	0.22 to < 0.39	0.39 to 18.32
	Eicosapentaenoic acid	0 to < 0.03	0.03 to < 0.07	0.07 to < 0.13	0.13 to 9.19
	Docosahexaenoic acid	0 to < 0.09	0.09 to < 0.16	0.16 to < 0.27	0.27 to 11.28
Omega-6 fatty acid		0.55 to < 4.32	4.32 to < 4.86	4.86 to < 5.45	5.45 to 13.95
	Linoleic acid	0.55 to < 4.23	4.23 to < 4.77	4.77 to < 5.34	5.34 to 13.95
	Arachidonic acid	0 to < 0.05	0.05 to < 0.08	0.08 to < 0.12	0.12 to 1.49

Table 3.

Adjusted hazard ratios and 95% confidence intervals for colorectal cancer risk by omega-3 and -6 fatty acid intake levels

Type of polyunsaturated fatty acid			Quartile 1 (lowest 25%)	Quartile 2 (25th to 50th percentile)	Quartile 3 (50th to 75th percentile)	Quartile 4 (highest 25%)	p for trend^a)	HR per an 1 g/day increment
Colorectum
	Omega-3 fatty acid		Reference	1.38 (0.99-1.91)	1.15 (0.83-1.61)	1.21 (0.88-1.67)	0.558	0.99 (0.82-1.19)
		Alpha-linolenic acid	Reference	0.94 (0.67-1.30)	1.29 (0.95-1.75)	1.17 (0.86-1.59)	0.112	1.30 (0.90-1.86)
		Docosapentaenoic acid	Reference	1.02 (0.75-1.38)	0.73 (0.53-1.01)	0.96 (0.71-1.29)	0.420	0.29 (0.02-4.42)
		Fish oil-derived omega-3	Reference	1.01 (0.73-1.38)	0.81 (0.59-1.12)	0.97 (0.72-1.32)	0.606	0.88 (0.65-1.17)
		Eicosapentaenoic acid	Reference	0.89 (0.65-1.22)	0.70 (0.50-0.96)	0.92 (0.69-1.24)	0.436	0.76 (0.38-1.50)
		Docosahexaenoic acid	Reference	0.91 (0.66-1.24)	0.79 (0.58-1.09)	0.91 (0.67-1.22)	0.431	0.79 (0.50-1.25)
	Omega-6 fatty acid		Reference	1.25 (0.90-1.72)	1.30 (0.94-1.78)	1.37 (1.00-1.87)	0.056	1.13 (1.01-1.26)
		Linoleic acid	Reference	1.28 (0.93-1.77)	1.37 (0.99-1.88)	1.40 (1.02-1.92)	0.038	1.14 (1.02-1.27)
		Arachidonic acid	Reference	0.84 (0.62-1.14)	0.85 (0.63-1.15)	0.79 (0.58-1.07)	0.161	0.28 (0.05-1.48)
Colon
	Omega-3 fatty acid		Reference	1.33 (0.88-2.02)	1.03 (0.67-1.58)	1.18 (0.79-1.78)	0.757	0.94 (0.73-1.22)
		Alpha-linolenic acid	Reference	0.86 (0.57-1.29)	1.13 (0.77-1.65)	0.96 (0.65-1.41)	0.833	1.04 (0.64-1.69)
		Docosapentaenoic acid	Reference	1.06 (0.72-1.57)	0.76 (0.50-1.16)	0.95 (0.64-1.40)	0.470	0.16 (0.004-6.35)
		Fish oil-derived omega-3	Reference	1.13 (0.74-1.72)	0.98 (0.64-1.51)	1.25 (0.84-1.87)	0.354	0.91 (0.63-1.30)
		Eicosapentaenoic acid	Reference	0.89 (0.59-1.35)	0.77 (0.51-1.18)	1.11 (0.76-1.62)	0.608	0.82 (0.35-1.92)
		Docosahexaenoic acid	Reference	1.10 (0.72-1.68)	0.98 (0.64-1.50)	1.19 (0.80-1.78)	0.481	0.83 (0.47-1.48)
	Omega-6 fatty acid		Reference	1.19 (0.80-1.76)	1.08 (0.73-1.62)	1.09 (0.73-1.62)	0.823	1.02 (0.88-1.18)
		Linoleic acid	Reference	1.16 (0.78-1.72)	1.16 (0.78-1.73)	1.08 (0.73-1.62)	0.708	1.03 (0.88-1.19)
		Arachidonic acid	Reference	0.81 (0.55-1.20)	0.79 (0.54-1.17)	0.79 (0.54-1.17)	0.251	0.13 (0.01-1.30)
Rectum
	Omega-3 fatty acid		Reference	1.46 (0.85-2.48)	1.36 (0.80-2.30)	1.25 (0.74-2.12)	0.589	1.04 (0.81-1.34)
		Alpha-linolenic acid	Reference	1.10 (0.63-1.92)	1.62 (0.98-2.69)	1.61 (0.98-2.66)	0.025	1.73 (1.02-2.93)
		Docosapentaenoic acid	Reference	0.94 (0.58-1.54)	0.68 (0.40-1.14)	0.97 (0.61-1.55)	0.694	0.65 (0.01-33.63)
		Fish oil-derived omega-3	Reference	0.88 (0.55-1.40)	0.62 (0.38-1.03)	0.67 (0.42-1.08)	0.050	0.83 (0.51-1.34)
		Eicosapentaenoic acid	Reference	0.89 (0.56-1.43)	0.60 (0.37-1.00)	0.69 (0.43-1.11)	0.062	0.66 (0.21-2.09)
		Docosahexaenoic acid	Reference	0.71 (0.44-1.15)	0.59 (0.37-0.96)	0.62 (0.39-0.98)	0.035	0.73 (0.34-1.55)
	Omega-6 fatty acid		Reference	1.38 (0.79-2.42)	1.77 (1.03-3.01)	1.98 (1.17-3.32)	0.006	1.29 (1.10-1.52)
		Linoleic acid	Reference	1.57 (0.90-2.76)	1.83 (1.06-3.16)	2.11 (1.25-3.59)	0.005	1.30 (1.11-1.53)
		Arachidonic acid	Reference	0.89 (0.55-1.46)	0.95 (0.59-1.53)	0.79 (0.49-1.29)	0.418	0.73 (0.07-7.81)

Hazard ratios (HRs) are adjusted for body mass index (kg/m²; < 25, 25-30, ≥ 30, or missing), education (years; ≤ 10, 11-13, or > 13), smoking history (never or ever), and alcohol intake (g/day; < 5, 5-25, ≥ 25). Total caloric intake was adjusted by the residual method.

^a) p-trend was estimated by using the order of the quartile groups.

REFERENCES

1. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935–45. Article PubMed PDF
2. Chen GC, Qin LQ, Lu DB, Han TM, Zheng Y, Xu GZ, et al. N-3 polyunsaturated fatty acids intake and risk of colorectal cancer: meta-analysis of prospective studies. Cancer Causes Control. 2015;26:133–41. Article PubMed PDF
3. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective. Continuous update project expert report 2018 [Internet]. London: World Cancer Research Fund; 2019. [cited 2019 Sep 10]. Available from: https://dietandcancerreport.org
4. Wu S, Feng B, Li K, Zhu X, Liang S, Liu X, et al. Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med. 2012;125:551–9. Article PubMed
5. Song M, Chan AT, Fuchs CS, Ogino S, Hu FB, Mozaffarian D, et al. Dietary intake of fish, omega-3 and omega-6 fatty acids and risk of colorectal cancer: a prospective study in U.S. men and women. Int J Cancer. 2014;135:2413–23. Article PubMed PMC
6. Larsson SC, Rafter J, Holmberg L, Bergkvist L, Wolk A. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer. 2005;113:829–34. Article PubMed
7. Roswall N, Sandin S, Adami HO, Weiderpass E. Cohort profile: the Swedish Women's Lifestyle and Health cohort. Int J Epidemiol. 2017;46:e8Article PubMed PDF
8. Lof M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami HO, et al. Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer. 2007;97:1570–6. Article PubMed PMC PDF
9. Hedelin M, Lof M, Sandin S, Adami HO, Weiderpass E. Prospective study of dietary phytoestrogen intake and the risk of colorectal cancer. Nutr Cancer. 2016;68:388–95. Article PubMed
10. Shin A, Sandin S, Lof M, Margolis KL, Kim K, Couto E, et al. Alcohol consumption, body mass index and breast cancer risk by hormone receptor status: Women' Lifestyle and Health Study. BMC Cancer. 2015;15:881.Article PubMed PMC PDF
11. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72–80. Article PubMed PDF
12. Kato I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Riboli E. Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Nutr Cancer. 1997;28:276–81. Article PubMed
13. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97:906–16. Article PubMed PMC PDF
14. Engeset D, Andersen V, Hjartaker A, Lund E. Consumption of fish and risk of colon cancer in the Norwegian Women and Cancer (NOWAC) study. Br J Nutr. 2007;98:576–82. Article PubMed
15. Pham NM, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, et al. Fish consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2013;43:935–41. Article PubMed PDF
16. Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, et al. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control. 2002;13:383–93. Article PubMed
17. Spencer EA, Key TJ, Appleby PN, Dahm CC, Keogh RH, Fentiman IS, et al. Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort consortium. Cancer Causes Control. 2010;21:1417–25. Article PubMed PDF
18. Yu XF, Zou J, Dong J. Fish consumption and risk of gastrointestinal cancers: a meta-analysis of cohort studies. World J Gastroenterol. 2014;20:15398–412. Article PubMed PMC
19. Aglago EK, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T, et al. Consumption of fish and long-chain n-3 polyunsaturated fatty acids is associated with reduced risk of colorectal cancer in a large European cohort. Clin Gastroenterol Hepatol. 2020;18:654–66. Article PubMed
20. Shin A, Joo J, Bak J, Yang HR, Kim J, Park S, et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS One. 2011;6:e23196Article PubMed PMC
21. Lu C, Sun T, Li Y, Zhang D, Zhou J, Su X. Microbial diversity and composition in different gut locations of hyperlipidemic mice receiving krill oil. Appl Microbiol Biotechnol. 2018;102:355–66. Article PubMed PDF
22. Iigo M, Nakagawa T, Ishikawa C, Iwahori Y, Asamoto M, Yazawa K, et al. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer. 1997;75:650–5. Article PubMed PMC PDF
23. Cha MC, Lin A, Meckling KA. Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity. BMC Pharmacol. 2005;5:7.Article PubMed PMC
24. Gomez de Segura IA, Valderrabano S, Vazquez I, Vallejo-Cremades MT, Gomez-Garcia L, Sanchez M, et al. Protective effects of dietary enrichment with docosahexaenoic acid plus protein in 5-fluorouracil-induced intestinal injury in the rat. Eur J Gastroenterol Hepatol. 2004;16:479–85. Article PubMed
25. Livsmedelsverket: Swedish Food Agency. Riksmaten 2010 [Internet]. Uppsala: Swedish Food Agency; 2012. [cited 2019 Sep 10]. Available from: https://www.livsmedelsverket.se/matvanor-halsa--miljo/kostrad-och-matvanor/matvanor---undersokningar/riksmaten-2010-11---vuxna
26. Terry P, Bergkvist L, Holmberg L, Wolk A. No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:913–4. PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Associations between diet and nutritional supplements and colorectal cancer: A systematic review
Maryam Gholamalizadeh, Shirin Tajadod, Nazanin Majidi, Zohreh Aghakhaninejad, Zahra Mahmoudi, Zahra Mousavi, Arezoo Amjadi, Farkhondeh Alami, Mahdie Torkaman, Zahra Saeedirad, Saeid Doaei, Hanieh Shafaei, Naser Kalantari
JGH Open.2024;[Epub] CrossRef
Adherence to the Mediterranean diet and its protective effects against colorectal cancer: a meta-analysis of 26 studies with 2,217,404 participants
Zoltan Ungvari, Mónika Fekete, János Tibor Fekete, Giuseppe Grosso, Anna Ungvari, Balázs Győrffy
GeroScience.2024;[Epub] CrossRef
A higher dietary alpha-linolenic acid intake is associated with lower colorectal cancer risk based on MUC4 rs2246901 variant among Korean adults
Ha Thi Mien Nguyen, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Nutrition Research.2024; 131: 71. CrossRef
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer
Ramani Soundararajan, Michelle M Maurin, Jetsen Rodriguez-Silva, Gunjan Upadhyay, Ashley J Alden, Siddabasave Gowda B Gowda, Michael J Schell, Mingli Yang, Noah Jhad Levine, Divyavani Gowda, Punith M Sundaraswamy, Shu-Ping Hui, Lance Pflieger, Heiman Wang
Gut.2024; : gutjnl-2024-332535. CrossRef
Association between dietary intake of n‐3 polyunsaturated fatty acids and risk of colorectal cancer in the Japanese population: The Japan Collaborative Cohort Study
Ayako Kato, Chika Okada, Ehab S. Eshak, Hiroyasu Iso, Akiko Tamakoshi
Cancer Medicine.2023; 12(4): 4690. CrossRef
Serum levels of n-3 PUFA and colorectal cancer risk in Chinese population
Dan-Dan Shi, Yu-Jing Fang, Yi-Ling Jiang, Ting Dong, Zhuo-Lin Zhang, Ting Ma, Ruo-Lin Zhou, Qing-Jian Ou, Cai-Xia Zhang
British Journal of Nutrition.2023; 130(7): 1239. CrossRef
Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment
Alireza Tojjari, Khalil Choucair, Arezoo Sadeghipour, Azhar Saeed, Anwaar Saeed
Cancers.2023; 15(17): 4294. CrossRef
Nutritional Issues for Colorectal Cancer Prevention
Soyeon Jeong, Jung Ho Kim
Journal of Digestive Cancer Research.2023; 11(2): 77. CrossRef
Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer
Joanna Aldoori, Andrew J Cockbain, Giles J Toogood, Mark A Hull
Gut.2022; 71(4): 822. CrossRef
Inverse Association between Canned Fish Consumption and Colorectal Cancer Risk: Analysis of Two Large Case–Control Studies
Carlotta Franchi, Ilaria Ardoino, Cristina Bosetti, Eva Negri, Diego Serraino, Anna Crispo, Attilio Giacosa, Elena Fattore, Alberto Dolci, Francesca Bravi, Federica Turati, Carlo La Vecchia, Barbara D’Avanzo
Nutrients.2022; 14(8): 1663. CrossRef
Association of Dietary Intake and Biomarker of α-Linolenic Acid With Incident Colorectal Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies
Ze-Bin Dai, Xiao-Li Ren, Yi-Lang Xue, Ya Tian, Bing-Bing He, Chang-Long Xu, Bo Yang
Frontiers in Nutrition.2022;[Epub] CrossRef
Association between Dietary Fatty Acid Patterns and Colorectal Cancer Risk: A Large-Scale Case-Control Study in China
Kexin Tu, Ting Ma, Ruolin Zhou, Lei Xu, Yujing Fang, Caixia Zhang
Nutrients.2022; 14(20): 4375. CrossRef
Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer
Han Zhou, Yanping Chen, Yu Xiao, Qian Wu, Hui Li, Yi Li, Guangjian Su, Longfeng Ke, Junxin Wu, Jinluan Li
Frontiers in Immunology.2022;[Epub] CrossRef
Dietary fatty acids and colorectal cancer risk in men: A report from the Shanghai Men's Health Study and a meta‐analysis
Sang Nguyen, Honglan Li, Danxia Yu, Hui Cai, Jing Gao, Yutang Gao, Hung N. Luu, Huong Tran, Yong‐Bing Xiang, Wei Zheng, Xiao‐Ou Shu
International Journal of Cancer.2021; 148(1): 77. CrossRef
Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment
Junge Bai, Hongsheng Chen, Xuefeng Bai
Journal of Clinical Laboratory Analysis.2021;[Epub] CrossRef
The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies
Federica Ungaro, Silvia D’Alessio, Silvio Danese
Cancers.2020; 12(8): 2060. CrossRef
N-6 Polyunsaturated Fatty Acids and Risk of Cancer: Accumulating Evidence from Prospective Studies
Youngyo Kim, Jeongseon Kim
Nutrients.2020; 12(9): 2523. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Omega-3 and -6 Fatty Acid Intake and Colorectal Cancer Risk in Swedish Women’s Lifestyle and Health Cohort

Cancer Res Treat. 2020;52(3):848-854. Published online March 6, 2020

DOI: https://doi.org/10.4143/crt.2019.550

XML Download

Top of article

Abstract
Introduction
Materials and Methods
Results
Discussion
NOTES
REFERENCES

Omega-3 and -6 Fatty Acid Intake and Colorectal Cancer Risk in Swedish Women’s Lifestyle and Health Cohort

Characteristic		Entire cohort participants	Energy-adjusted omega-3 intake quartile (g/day)				p-value
Characteristic		Entire cohort participants	Quartile 1 (lowest 25%) 0.12 to < 1.08	Quartile 2 (25th to 50th percentile) 1.08 to < 1.29	Quartile 3 (50th to 75th percentile) 1.29 to < 1.57	Quartile 4 (highest 25%) 1.57-22.66	p-value
No. of participants		48,223	12,056	12,055	12,056	12,056
Age at enrollment (yr)		39.7±5.7	38.2±5.7	39.0±5.7	40.1±5.7	41.4±5.5	< 0.001
Body mass index (kg/m²)
	< 25	33,639 (69.8)	8,391 (69.6)	8,611 (71.4)	8,521 (70.7)	8,116 (67.3)	< 0.001
	25-29	10,098 (20.9)	2,484 (20.6)	2,393 (19.9)	2,525 (20.9)	2,696 (22.4)
	≥ 30	2,675 (5.5)	677 (5.6)	649 (5.4)	610 (5.1)	739 (6.1)
	Missing	1,811 (3.8)	504 (4.2)	402 (3.3)	400 (3.3)	505 (4.2)
Education (yr)
	≤ 10	14,129 (29.3)	3,111 (25.8)	3,200 (26.5)	3,575 (29.7)	4,243 (35.2)	< 0.001
	11-13	18,513 (38.4)	4,843 (40.2)	4,805 (39.9)	4,552 (37.8)	4,313 (35.8)
	> 13	14,639 (30.4)	3,901 (32.4)	3,831 (31.8)	3,693 (30.6)	3,214 (26.7)
	Missing	942 (2.0)	201 (1.7)	219 (1.8)	236 (2.0)	286 (2.4)
Smoking
	Never	19,525 (40.5)	5,001 (41.5)	5,018 (41.6)	5,061 (42.0)	4,445 (36.9)	< 0.001
	Ever	28,550 (59.2)	7,019 (58.2)	7,013 (58.2)	6,963 (57.8)	7,555 (62.7)
	Missing	148 (0.3)	36 (0.3)	24 (0.2)	32 (0.3)	56 (0.5)
Alcohol intake (g/day)
	< 5	36,192 (75.1)	9,116 (75.6)	8,969 (74.4)	9,060 (75.1)	9,047 (75.0)	< 0.001
	5-25	11,822 (24.5)	2,852 (23.7)	3,029 (25.1)	2,956 (24.5)	2,985 (24.8)
	≥ 25	209 (0.4)	88 (0.7)	57 (0.5)	40 (0.3)	24 (0.2)
Energy intake (kcal/day)		1,555±452	1,738±462	1,666±416	1,538±390	1,280±396	< 0.001
Colorectal cancer cases		334	60	90	84	100
Follow-up (yr)		21.1±0.7	21.1±0.6	21.1±0.7	21.1±0.6	21.1±0.8
Cumulative follow-up (yr)		1,018,700.7	254,665.6	254,589.0	254,826.5	254,619.6

Type		Quartile 1 (lowest 25%)	Quartile 2 (25th to 50th percentile)	Quartile 3 (50th to 75th percentile)	Quartile 4 (highest 25%)
Omega-3 fatty acid		0.12 to < 1.08	1.08 to < 1.29	1.29 to < 1.57	1.57 to 22.66
	Alpha-linolenic acid	0.12 to < 0.84	0.84 to < 0.98	0.98 to < 1.16	1.16 to 4.47
	Docosapentaenoic acid	0 to < 0.02	0.02 to < 0.03	0.03 to < 0.05	0.05 to 1.34
	Fish oil-derived omega-3	0 to < 0.12	0.12 to < 0.22	0.22 to < 0.39	0.39 to 18.32
	Eicosapentaenoic acid	0 to < 0.03	0.03 to < 0.07	0.07 to < 0.13	0.13 to 9.19
	Docosahexaenoic acid	0 to < 0.09	0.09 to < 0.16	0.16 to < 0.27	0.27 to 11.28
Omega-6 fatty acid		0.55 to < 4.32	4.32 to < 4.86	4.86 to < 5.45	5.45 to 13.95
	Linoleic acid	0.55 to < 4.23	4.23 to < 4.77	4.77 to < 5.34	5.34 to 13.95
	Arachidonic acid	0 to < 0.05	0.05 to < 0.08	0.08 to < 0.12	0.12 to 1.49

Type of polyunsaturated fatty acid			Quartile 1 (lowest 25%)	Quartile 2 (25th to 50th percentile)	Quartile 3 (50th to 75th percentile)	Quartile 4 (highest 25%)	p for trend^a)	HR per an 1 g/day increment
Colorectum
	Omega-3 fatty acid		Reference	1.38 (0.99-1.91)	1.15 (0.83-1.61)	1.21 (0.88-1.67)	0.558	0.99 (0.82-1.19)
		Alpha-linolenic acid	Reference	0.94 (0.67-1.30)	1.29 (0.95-1.75)	1.17 (0.86-1.59)	0.112	1.30 (0.90-1.86)
		Docosapentaenoic acid	Reference	1.02 (0.75-1.38)	0.73 (0.53-1.01)	0.96 (0.71-1.29)	0.420	0.29 (0.02-4.42)
		Fish oil-derived omega-3	Reference	1.01 (0.73-1.38)	0.81 (0.59-1.12)	0.97 (0.72-1.32)	0.606	0.88 (0.65-1.17)
		Eicosapentaenoic acid	Reference	0.89 (0.65-1.22)	0.70 (0.50-0.96)	0.92 (0.69-1.24)	0.436	0.76 (0.38-1.50)
		Docosahexaenoic acid	Reference	0.91 (0.66-1.24)	0.79 (0.58-1.09)	0.91 (0.67-1.22)	0.431	0.79 (0.50-1.25)
	Omega-6 fatty acid		Reference	1.25 (0.90-1.72)	1.30 (0.94-1.78)	1.37 (1.00-1.87)	0.056	1.13 (1.01-1.26)
		Linoleic acid	Reference	1.28 (0.93-1.77)	1.37 (0.99-1.88)	1.40 (1.02-1.92)	0.038	1.14 (1.02-1.27)
		Arachidonic acid	Reference	0.84 (0.62-1.14)	0.85 (0.63-1.15)	0.79 (0.58-1.07)	0.161	0.28 (0.05-1.48)
Colon
	Omega-3 fatty acid		Reference	1.33 (0.88-2.02)	1.03 (0.67-1.58)	1.18 (0.79-1.78)	0.757	0.94 (0.73-1.22)
		Alpha-linolenic acid	Reference	0.86 (0.57-1.29)	1.13 (0.77-1.65)	0.96 (0.65-1.41)	0.833	1.04 (0.64-1.69)
		Docosapentaenoic acid	Reference	1.06 (0.72-1.57)	0.76 (0.50-1.16)	0.95 (0.64-1.40)	0.470	0.16 (0.004-6.35)
		Fish oil-derived omega-3	Reference	1.13 (0.74-1.72)	0.98 (0.64-1.51)	1.25 (0.84-1.87)	0.354	0.91 (0.63-1.30)
		Eicosapentaenoic acid	Reference	0.89 (0.59-1.35)	0.77 (0.51-1.18)	1.11 (0.76-1.62)	0.608	0.82 (0.35-1.92)
		Docosahexaenoic acid	Reference	1.10 (0.72-1.68)	0.98 (0.64-1.50)	1.19 (0.80-1.78)	0.481	0.83 (0.47-1.48)
	Omega-6 fatty acid		Reference	1.19 (0.80-1.76)	1.08 (0.73-1.62)	1.09 (0.73-1.62)	0.823	1.02 (0.88-1.18)
		Linoleic acid	Reference	1.16 (0.78-1.72)	1.16 (0.78-1.73)	1.08 (0.73-1.62)	0.708	1.03 (0.88-1.19)
		Arachidonic acid	Reference	0.81 (0.55-1.20)	0.79 (0.54-1.17)	0.79 (0.54-1.17)	0.251	0.13 (0.01-1.30)
Rectum
	Omega-3 fatty acid		Reference	1.46 (0.85-2.48)	1.36 (0.80-2.30)	1.25 (0.74-2.12)	0.589	1.04 (0.81-1.34)
		Alpha-linolenic acid	Reference	1.10 (0.63-1.92)	1.62 (0.98-2.69)	1.61 (0.98-2.66)	0.025	1.73 (1.02-2.93)
		Docosapentaenoic acid	Reference	0.94 (0.58-1.54)	0.68 (0.40-1.14)	0.97 (0.61-1.55)	0.694	0.65 (0.01-33.63)
		Fish oil-derived omega-3	Reference	0.88 (0.55-1.40)	0.62 (0.38-1.03)	0.67 (0.42-1.08)	0.050	0.83 (0.51-1.34)
		Eicosapentaenoic acid	Reference	0.89 (0.56-1.43)	0.60 (0.37-1.00)	0.69 (0.43-1.11)	0.062	0.66 (0.21-2.09)
		Docosahexaenoic acid	Reference	0.71 (0.44-1.15)	0.59 (0.37-0.96)	0.62 (0.39-0.98)	0.035	0.73 (0.34-1.55)
	Omega-6 fatty acid		Reference	1.38 (0.79-2.42)	1.77 (1.03-3.01)	1.98 (1.17-3.32)	0.006	1.29 (1.10-1.52)
		Linoleic acid	Reference	1.57 (0.90-2.76)	1.83 (1.06-3.16)	2.11 (1.25-3.59)	0.005	1.30 (1.11-1.53)
		Arachidonic acid	Reference	0.89 (0.55-1.46)	0.95 (0.59-1.53)	0.79 (0.49-1.29)	0.418	0.73 (0.07-7.81)

Table 1. Characteristics of study population by omega-3 intake quartile at baseline

Values are presented as mean±standard deviation or number (%). p-values were calculated by chi-square test for categorical variables and ANOVA for continuous variables.

Table 2. Quartile distribution of omega-3 and -6 fatty acid of study population (g/day)

Table 3. Adjusted hazard ratios and 95% confidence intervals for colorectal cancer risk by omega-3 and -6 fatty acid intake levels

p-trend was estimated by using the order of the quartile groups.